SOLD: 4,500 sq ft standard processor with rec sales licence bargain-priced at 600K!
One-time opportunity to purchase BC-based licensed 'standard processor' with rec sales licence for 600K
Listing ID:
6816796284
Licence(s) Held:
Standard Processing, Recreational Sales Amendment
Listing Details:
Two-storey, purpose designed, ~4,500 ft.² standard processing facility in a standalone building.
The licensed site is on a long-term, low-cost lease ($9,500 per month).
$1.9 million spent building the business, including customized cannabis facility build-out.
100K+ of equipment included in sale price.
Suitable for dried cannabis flower packaging, pre-roll production, contract packaging, B2B sales and distribution.
Capability to generate $4 to $5+ million annual revenue.
Excellent opportunity for a new independent operator or growing LP looking for a Western Canadian sales and distribution hub.
Existing key personnel (with Security Clearance) willing to support the transition to a new owner and open to discussion about longer-term employment.
OUR NEWEST CANNABIS BUSINESS LISTINGS
Explore the newest cannabis business opportunities hitting the market. If you're looking to invest, acquire, or expand your enterprise, these listings are the ideal starting point to grow your footprint in the cannabis industry.
36324927098
Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner
Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential
29345918591
State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub
Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.